Logo

GeneOhm Licenses Sequencing Technology from University of Rochester

Feb 16, 2004

NEW YORK, Feb. 16 (GenomeWeb News) - GeneOhm Sciences has licensed a nucleic acid-synthesis and -amplification technology from the e Universityof Rochester, the company said today.

 

The non-exclusive license will help GeneOhm develop molecular diagnostic assays to identify gene sequences to certain undisclosed diseases, the company said.

The nucleic acid synthesis technology developed at the Universityof Rochester"offers the potential to differentiate and amplify specific DNA sequences faster and at a lower cost than other methods," GeneOhm said.

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.